News
- Author:
- John Jesitus
Publish date: November 26, 2024
Members of the multidisciplinary Low-Dose Oral Minoxidil Initiation steering committee recruited dermatologists with hair loss expertise from 12 co...
News
- Author:
- John Jesitus
Publish date: November 20, 2024
The study authors reported that COVID-19 vaccination appears to reduce these risks.
News
- Author:
- John Jesitus
Publish date: November 14, 2024
“The gradual accumulation of physical and cognitive disability is driven by smoldering pathological processes via biological substrates, which are ...
News
- Author:
- John Jesitus
Publish date: October 25, 2024
“Trichophyton indotineae is changing the way we talk about dermatophyte infections,” said Avrom S. Caplan, MD, a dermatologist at New York...
News
- Author:
- John Jesitus
Publish date: October 4, 2024
A prospective, double-blind, randomized, placebo-controlled trial showed that patients with chronic migraine and nonopioid medication overuse heada...
News
- Author:
- John Jesitus
Publish date: September 30, 2024
Used appropriately, newer treatments for myasthenia gravis can provide dramatic results faster and more safely than broad immunosuppressants.
News
- Author:
- John Jesitus
Publish date: September 9, 2024
Understanding how MS may protect patients from Alzheimer’s disease may drive new treatment strategies.
News
- Author:
- John Jesitus
Publish date: August 6, 2024
Neurite orientation dispersion and density imaging (NODDI) “will allow us to correlate symptoms with brain structural changes, making the invisible...
News
- Author:
- John Jesitus
Publish date: July 24, 2024
“We identified specific subgroups within the sexual minority community who are at higher risk for skin cancer,” said study author Matthew Mansh, MD...
News
- Author:
- John Jesitus
Publish date: July 18, 2024
Incidence of benign skin reactions such as morbilliform exanthematous eruptions, which account for 95% of cutaneous adverse drug reactions, ranges ...
News
- Author:
- John Jesitus
Publish date: June 19, 2024
Results could help physicians address patients at risk of Alzheimer’s disease who reject relevant testing because they believe nothing can forestal...
News
- Author:
- John Jesitus
Publish date: June 14, 2024
The findings could improve GLP-1 implementation by stroke specialists in patients with stroke history and concurrent type 2 diabetes or obesity.
News
- Author:
- John Jesitus
Publish date: June 4, 2024
Advances in identification of potential prodromal Parkinson’s disease biomarkers must be weighed against the pote...
News
- Author:
- John Jesitus
Publish date: May 20, 2024
Clinical prediction models can help neurologists identify which patients could benefit from more aggressive early treatment.
News
- Author:
- John Jesitus
Publish date: April 25, 2024
In a small, nonrandomized controlled trial, the injectable calcitonin gene-related peptide (CGRP) in...
